Kainova Therapeutics Expands Phase I / II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe
Article Date
April 9, 2026
This article is featured on another website.
Go to article
August 4, 2026
HIRO to Attend the SCDM Annual Conference 2026 in Raleigh, North Carolina
Find HiRO at SCDM 2026 at Booth #526 HiRO is excited to announce our attendance…
August 4, 2026
HIRO to Attend the SCDM Annual Conference 2026 in Raleigh, North Carolina
Find HiRO at SCDM 2026 at Booth #526 HiRO is excited to announce our attendance…